Skip to main content

Table 1 Demographic information and clinical characteristics

From: Investigation of the effect of N-acetylcysteine on serum levels of oxidative inflammatory biomarkers in patients with stroke

Variable

Intervention group

Control group

p value

Age, (year)

62.48 ± 11.43

62.71 ± 12.11

0.94

Male, n (%)

20 (54.0)

25 (67)

0.16

Female, n (%)

17 (46.0)

12 (33)

 

DM, n (%)

6 (19.35)

9 (29.03)

0.45

HLP, n (%)

3 (9.67)

6 (19.35)

0.27

HTN, n (%)

16 (51.61)

15 (48.38)

0.65

Smoking, n (%)

11 (35.48)

6 (19.35)

0.15

Glucose (mg/dl)

130.13 ± 38.43

146.13 ± 82.18

0.33

LDL (mg/dl)

115.63 ± 34.25

110.55 ± 34.87

0.64

HDL (mg/dl)

37.68 ± 9.25

40.60 ± 9.70

0.34

  1. DM Diabetes mellitus, HLP Hyperlipidemia, HTN Hypertension, LDL Low-density lipoprotein, HDL high-density lipoprotein